EDC vendor validation – Clinical Research Made Simple https://www.clinicalstudies.in Trusted Resource for Clinical Trials, Protocols & Progress Thu, 24 Jul 2025 06:36:51 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.1 eCRF Validation and UAT Before Go-Live https://www.clinicalstudies.in/ecrf-validation-and-uat-before-go-live/ Thu, 24 Jul 2025 06:36:51 +0000 https://www.clinicalstudies.in/ecrf-validation-and-uat-before-go-live/ Read More “eCRF Validation and UAT Before Go-Live” »

]]>
eCRF Validation and UAT Before Go-Live

Preparing for Go-Live: Validating eCRFs and Conducting UAT Effectively

Introduction: Why eCRF Validation and UAT Are Critical

Electronic Case Report Form (eCRF) validation and User Acceptance Testing (UAT) are essential pre-launch steps in ensuring an Electronic Data Capture (EDC) system performs as intended. Without rigorous validation, issues like incorrect edit checks, missing fields, or broken logic can slip into production and compromise data quality or regulatory compliance.

This tutorial guides clinical teams and data managers through the structured approach to eCRF validation and UAT, emphasizing test planning, execution, documentation, and regulatory expectations before go-live.

1. Understanding eCRF Validation in Clinical Trials

Validation refers to confirming that the eCRF and the broader EDC system perform reliably, accurately, and consistently as per predefined specifications. It includes:

  • Testing all programmed logic, including edit checks and calculations
  • Ensuring alignment with the protocol and statistical analysis plan
  • Documenting all results for audit readiness

Validation must follow principles defined in GAMP5 and GxP. For instance, changes in CRF versions after validation must trigger re-validation activities with full traceability.

2. Building a Validation Strategy and Plan

Every validation effort starts with a documented plan that includes:

  • Scope of systems (eCRF modules, edit checks, integrations)
  • Testing methodology (manual vs automated scripts)
  • Roles and responsibilities
  • Exit criteria and approval processes

The plan should also address risk assessment and mitigation strategies. For example, high-risk forms like Serious Adverse Event (SAE) forms may require deeper testing coverage than low-risk forms like Demographics.

3. Developing Test Scripts and Scenarios

Detailed test scripts guide validation testing. Each script includes:

  • Test objective (e.g., Validate skip logic for SAE Follow-up)
  • Steps to execute
  • Expected result
  • Pass/Fail outcome

Below is a sample test scenario table:

Test ID Test Objective Expected Result Status
UAT-001 Test Gender field dropdown Options: Male, Female, Other Pass
UAT-005 Edit check: ALT > 100 triggers query Query popup displayed Pass

Checklists from platforms like PharmaSOP.in offer industry-standard UAT templates and test cases.

4. Conducting User Acceptance Testing (UAT)

UAT is the final testing phase before system deployment. It’s performed by end users—typically data managers, CRAs, or sponsor representatives—under realistic scenarios. Key UAT steps include:

  • Testing user workflows: site login, CRF completion, save/submit
  • Checking edit check behavior across boundary values
  • Running system-generated reports and listings

All findings during UAT should be logged in a formal issue tracker with severity ratings. Critical issues must be fixed and re-tested before the UAT summary report is approved.

5. Defect Management and Revalidation

No validation process is complete without defect tracking. Each bug should include:

  • Description and screenshots
  • Assigned owner for resolution
  • Root cause analysis
  • Corrective action and retesting evidence

For example, if the SAE form fails to save due to a JavaScript error, a detailed resolution should follow with a re-test pass logged in the validation matrix.

6. Documentation for Audit Readiness

To be GxP-compliant, documentation must be thorough and include:

  • Validation Plan
  • Test Scripts and Results
  • Issue Logs and Resolutions
  • UAT Summary Report
  • Approval signatures

Regulators such as the EMA expect this documentation to be maintained in the Trial Master File (TMF). Missing or incomplete documentation has been a common inspection finding during FDA audits.

7. Go-Live Readiness and Sign-Off

Once UAT is successfully completed and all critical issues are resolved, a formal sign-off is conducted. This usually involves:

  • Review of validation package by QA or compliance
  • Confirmation of system backup and recovery setup
  • Final approvals from study sponsor or designated authority

The system is then deployed into production, marking the beginning of live data capture.

Conclusion: Validated eCRFs Build Trial Confidence

eCRF validation and UAT are not just checkbox exercises—they are critical quality gates that protect the study from errors, delays, and compliance failures. A well-tested and documented eCRF system leads to confident go-lives, faster data review, and smoother regulatory submissions.

Whether you’re preparing for a Phase I FIH trial or a global Phase III program, rigorous validation remains your best defense against post-launch complications.

]]>